USPTO serial 79324019
AMELIVU
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 4, 2022
- Examiner
- PARKS, KIMBERLY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AMELIVU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treating neovascular age-related macular degeneration; pharmaceutical preparations for treating diabetic macular edema; pharmaceutical preparations for the treatment of angiogenesis diseases and disorders; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; ocular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations, for immunoregulation and for the treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of inflammatory diseases; antidiabetic preparations; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical preparations for the prevention of ocular disorders or diseases; cardiovascular agents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; dietary supplements | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 26, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 10, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 10, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 3, 2022 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Oct 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 29, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 29, 2022 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2022 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Nov 23, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 3, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 28, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |